Paper37118348
Strategies To Stabilize Dalbavancin in Aqueous Solutions; Section 3: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Phosphate Buffer with and without Divalent Metal Ions.
Jakaria SM and 2 others. Pharm Res, 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Strategies To Stabilize Dalbavancin in Aqueous Solutions; Section 3: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Phosphate Buffer with and without Divalent Metal Ions. Papers, record 37118348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37118348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Strategies To Stabilize Dalbavancin in Aqueous Solutions; Section 3: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Phosphate Buffer with and without Divalent Metal Ions.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Excipients | Major topic |
| Teicoplanin | Major topic |
| 2-Hydroxypropyl-beta-cyclodextrin | |
| Water | |
| Drug Stability | |
| Hydrogen-Ion Concentration | |
| Solutions |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15750032 | Origin, structure, and activity in vitro and in vivo of dalbavancin. | J Antimicrob Chemother | 2005 | https://conductscience.org/library/papers/15750032 | PubMed |
| 2 | 17964744 | Stabilization of a polypeptide in non-aqueous solvents. | Int J Pharm | 2008 | https://conductscience.org/library/papers/17964744 | PubMed |
| 3 | 7373535 | Digoxin degradation in acidic dissolution medium. | J Pharm Sci | 1980 | https://conductscience.org/library/papers/7373535 | PubMed |
| 4 | 13178 | Hydrolysis of digoxin by acid. | J Pharm Pharmacol | 1977 | https://conductscience.org/library/papers/13178 | PubMed |
| 5 | 36530576 | Glycopeptide antibiotic drug stability in aqueous solution. | AAPS Open | 2022 | https://conductscience.org/library/papers/36530576 | PubMed |
| 6 | 30841519 | Bioproduction of Quercetin and Rutinose Catalyzed by Rutinosidase: Novel Concept of "Solid State Biocatalysis". | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30841519 | PubMed |
| 7 | 21039545 | Pharmaceutical applications of cyclodextrins: basic science and product development. | J Pharm Pharmacol | 2010 | https://conductscience.org/library/papers/21039545 | PubMed |
| 9 | 10934740 | Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin. | Pharm Dev Technol | 2000 | https://conductscience.org/library/papers/10934740 | PubMed |
| 10 | 20143256 | Stability of protein pharmaceuticals: an update. | Pharm Res | 2010 | https://conductscience.org/library/papers/20143256 | PubMed |
| 11 | 31587143 | Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site. | Adv Ther | 2019 | https://conductscience.org/library/papers/31587143 | PubMed |
| 12 | 15713062 | Oxytocin-receptor binding: why divalent metals are essential. | J Am Chem Soc | 2005 | https://conductscience.org/library/papers/15713062 | PubMed |
| 13 | 24105716 | Influence of hydroxypropyl-Beta-cyclodextrin on the stability of dilute and highly concentrated immunoglobulin g formulations. | J Pharm Sci | 2013 | https://conductscience.org/library/papers/24105716 | PubMed |
| 14 | 6128384 | Effect of cyclodextrins on the acid hydrolysis of digoxin. | J Pharm Pharmacol | 1982 | https://conductscience.org/library/papers/6128384 | PubMed |
| 15 | 7793894 | Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7793894 | PubMed |
| 16 | 9062068 | Interaction of oxytocin with Ca2+: II. Proton magnetic resonance and molecular modeling studies of conformations of the hormone and its Ca2+ complex. | Biopolymers | 1996 | https://conductscience.org/library/papers/9062068 | PubMed |
| 17 | 9876591 | Extension of the International Conference on Harmonization Tripartite Guideline for Stability Testing of New Drug Substances and Products to countries of climatic zones III and IV. | Drug Dev Ind Pharm | 1998 | https://conductscience.org/library/papers/9876591 | PubMed |
| 18 | 21448747 | A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer. | AAPS J | 2011 | https://conductscience.org/library/papers/21448747 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39771484 | Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-2: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Acetate Buffer with and Without Divalent Metal Ions. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39771484 | PubMed |
| 37697173 | Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-1: the Effects of Metal Ions and Buffers. | Pharm Res | 2023 | https://conductscience.org/library/papers/37697173 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37118348
GET https://conductscience.org/api/papers/v1/37118348/authors